Panagora Asset Management Inc Astria Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

  • $20.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024
BUY
$8.83 - $13.51 $139,655 - $213,674
15,816 Added 104.67%
30,926 $281,000
Q1 2024

May 07, 2024
SELL
$6.99 - $16.69 $2,460 - $5,874
-352 Reduced 2.28%
15,110 $212,000
Q4 2023

Feb 08, 2024
BUY
$4.42 - $8.06 $68,342 - $124,623
15,462 New
15,462 $118,000

Others Institutions Holding ATXS

# of Institutions
110
Shares Held
48.6M
Call Options Held
48K
Put Options Held
9.3K
View Full List

About Astria Therapeutics, Inc.

ATXS Quotes by TradingView
  • Ticker ATXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,178,000
  • Market Cap $115M
  • Description
  • Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...
More about ATXS
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email